Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy

NCT02891811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib
DRUG: Thalidomide
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Arbeitsgemeinschaft medikamentoese Tumortherapie

Collaborators

[object Object]